Thumbnail Image
Item

The Generic Biologics Debate: Industry’s Unintended Admission that Biotech Patents Fail Enablement

Mandel, Gregory N.
Citations
Altmetric:
Genre
Journal article
Date
2006
Advisor
Committee member
Group
Department
Subject
Industry
 Intellectual property law
 Food and drug law
Permanent link to this record
http://hdl.handle.net/20.500.12613/6363
Collections
Faculty/Researcher Works
Show all metadata
Research Projects
Organizational Units
Journal Issue
DOI
http://dx.doi.org/10.34944/dspace/6345
Abstract
This Article reveals that many already issued and actively enforced medical biotechnology patents may be invalid. Biologics, medical therapeutics derived through biotechnology techniques, are the fastest growing and most promising pharmaceutical sector. They represent a $45 billion a year industry that is anticipated to double in five years and that already provides novel treatments for cancer, diabetes, and heart disease. Due to unforeseen consequences of past decisions, manufacturers currently are significantly limited in their ability to sell generic copies of biologics even after the pioneer biologic patents expire. As early biologics are starting to go off-patent, this regulatory mix-up is having a notable impact on the availability of biologics and raising the cost of health care. The generic biologics debate has dramatically heated-up recently due to proposed legislation to create a new regulatory process for generic biologics, the biotechnology and pharmaceutical industry defending the status quo, and the Food and Drug Administration struggling to handle the situation. This Article exposes for the first time that industry's own arguments have an unintended, striking consequence many of their biologic patents fail enablement, and therefore are not valid in the first instance.
Description
Citation
Gregory N. Mandel, The Generic Biologics Debate: Industry’s Unintended Admission that Biotech Patents Fail Enablement, 11 Va. J. L. & Tech. 8 (2006).
Available at: https://www.vjolt.org/volume-11
Citation to related work
The University of Virginia School of Law
Has part
Virginia Journal of Law and Technology, Vol. 11, Iss. 4 (Fall 2006)
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
Embedded videos